Penn State Endrocrinology

 

 

Meet the Medical Team
Adult Services
Pediatric Services
Health Information
Fellowship Program
Patient Resources
Physician Resources
Research
News & Events
Links
Contact Us
Endocrinology Home

endocrinology Home

 

Meet the Team

Michael F. Verderame, Ph.DMichael F. Verderame, Ph.D.
Associate Professor
Department of Medicine, Division of Endocrinology, Diabetes and Metabolism

Assistant Professor
Department of Microbiology and Immunology

Graduate Program Affiliations:
Cell and Molecular Biology, Genetics, Microbiology and Immunology

Ph.D., Columbia University, 1984;
Postdoctoral Training, University of California, San Francisco, 1984-1989

Email: mverdera@psu.edu

Research Interests

Normal growth and development requires that every cell in the body respond appropriately to the many signals it receives from its environment - these signals include both circulating hormones as well as positional information conveyed by the structural milieu surrounding the cell. Processing of this information (known as signal transduction) is frequently disrupted in cancer.

The long term interest of my laboratory is understanding the molecular mechanisms that govern the highly complex but exquisitely orchestrated processes of normal growth and development, and how these processes are disrupted in disease states such as cancer

The major research focus of my laboratory is breast cancer - the most commonly diagnosed cancer in American women. Unfortunately the biochemical pathways altered in breast cancer remain poorly defined. Two PTKs of particular interest to us are HER2 and SRC. HER2 is critical for continued growth of a substantial fraction of breast cancers. SRC is suspected to also be important in breast cancer growth, although its exact role remains to be defined.

My laboratory’s current efforts to understand the role of HER2 and SRC in breast cancer employ a novel, 3-dimentional culture system that, unlike traditional culture systems, allows normal breast epithelial cells to differentiate. It is our belief that this more physiological system will ultimately allow us to understand the roles of HER2 and SRC in breast cancer, and identify critical targets for future drug development.


Selected Publications

Back

 

 

 

Penn State Medicine Magazine

 

For suggestions or comments about the Penn State Endocrinology website, please email Webmaster at medicine@hmc.psu.edu.



Penn State Milton S. Hershey Medical Center ©2004
This page was last updated on August 11, 2005
Contact Us